Valence 로고
인기
로그인
Loading data for SBFMW — first visit, this takes a few seconds.

관심목록에 추가

Sunshine Biopharma Inc.

NasdaqCM: SBFMW · 실시간 가격 · USD
0.05
+0.00 (0.00%)
종가 기준: Aug 19, 2026, 3:54 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

Sunshine Biopharma Inc.(SBFMW) 주가, 분석 및 데이터

0.00%

데이터 없음

매수호가n/a
시가총액n/a
매출 (ttm)35.35M
순이익 (ttm)-5.83M
1.31
-2.21
n/a
n/a
P/B (ttm)n/a
P/S (ttm)n/a
실적 발표일n/a
매도호가n/a
거래량2
평균 거래량 (20일)
시가0.24
전일 종가0.05
일중 범위0.05 - 0.05
52주 범위0.05 - 0.05
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

SBFMW 소개

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calciu...

[더 보기]
산업
섹터
IPO 일자 Jul 17, 2026
직원 수 50
상장 거래소 NasdaqCM
티커 SBFMW
웹사이트 https://sunshinebiopharma.com
전체 기업 정보

재무 실적

2025년 Sunshine Biopharma의 매출은 36.31M로, 전년 34.87M 대비 4.11% 증가했습니다. 순이익은 -5.98M로, 16.39% 증가했습니다.

재무제표
news image

1주 전 · Benzinga

EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug

Sunshine Biopharma Inc. (NASDAQ:SBFM) announced on Wednesday that it has secured regulatory approval to introduce its generic Enalapril tablets across the Canadian market, signaling a significant stra...

news image

3주 전 · Benzinga

EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval

Pharmaceutical firm Sunshine Biopharma Inc. (NASDAQ:SBFM) on Tuesday said it received regulatory approval to introduce its 2mg generic Dienogest tablets to the Canadian market. The significant milesto...